Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 418

1.
2.

Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.

Ageno W, Crowther M, Steidl L, Ultori C, Mera V, Dentali F, Squizzato A, Marchesi C, Venco A.

Thromb Haemost. 2002 Jul;88(1):48-51.

PMID:
12152676
3.

[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Angelo M, Stockner I, Wiedermann CJ.

Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Review. German.

PMID:
19052707
4.

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

Hanslik T, Prinseau J.

Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.

PMID:
14967065
5.

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.

Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W.

Ann Intern Med. 2002 Aug 20;137(4):251-4.

PMID:
12186515
6.

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

Denas G, Marzot F, Offelli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V.

J Thromb Thrombolysis. 2009 Apr;27(3):340-7. doi: 10.1007/s11239-008-0211-4. Epub 2008 Mar 13.

PMID:
18338109
7.

Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.

Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'malley PG.

Arch Intern Med. 2006 Feb 27;166(4):391-7.

PMID:
16505257
8.

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

Dentali F, Ageno W, Crowther M.

J Thromb Haemost. 2006 Sep;4(9):1853-63. Review.

9.
10.

The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Garcia DA, Regan S, Crowther M, Hylek EM.

J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. Epub 2006 Jan 26.

11.

What influence do anticoagulants have on oral implant therapy? A systematic review.

Madrid C, Sanz M.

Clin Oral Implants Res. 2009 Sep;20 Suppl 4:96-106. doi: 10.1111/j.1600-0501.2009.01770.x. Review.

PMID:
19663955
12.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
13.

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.

Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D.

Arch Intern Med. 2003 Nov 10;163(20):2469-73.

PMID:
14609783
14.

Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J.

Thromb Haemost. 1998 Jun;79(6):1116-8.

PMID:
9657434
15.

Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage.

Siddiq F, Jalil A, McDaniel C, Brock DG, Pineda CC, Bell RD, Lee K.

Neurocrit Care. 2008;8(1):36-41.

PMID:
17898941
16.

Self-management of oral anticoagulation therapy--methodological and clinical aspects.

Christensen TD.

Dan Med Bull. 2011 May;58(5):B4284. Review.

PMID:
21535992
17.
18.

A survey of oral vitamin K use by anticoagulation clinics.

Libby EN, Garcia DA.

Arch Intern Med. 2002 Sep 9;162(16):1893-6.

PMID:
12196089
19.

Retrospective and prospective analyses of the treatment of overanticoagulated patients.

Duong TM, Plowman BK, Morreale AP, Janetzky K.

Pharmacotherapy. 1998 Nov-Dec;18(6):1264-70.

PMID:
9855325
20.

Vitamin K for improved anticoagulation control in patients receiving warfarin.

Mahtani KR, Heneghan CJ, Nunan D, Roberts NW.

Cochrane Database Syst Rev. 2014 May 15;(5):CD009917. doi: 10.1002/14651858.CD009917.pub2. Review.

PMID:
24832594

Supplemental Content

Support Center